Tilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $0.61, marking a +1.21% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.54%. At the same time, the Dow added 0.52%, and the tech-heavy Nasdaq gained 0.74%. Coming into today, shares of the company had gained 57.24% in the past month. In that same time, the Medical sector lost 2.12%, while the S&P 500 gained 4.2%. Investors will be eagerly watching for the performance of Tilray Brands, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 28, 2025. It is anticipated that the company will report an EPS of -$0.03, marking a 25% rise compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $240.05 million, indicating a 4.42% increase compared to the same quarter of the previous year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.01 per share and revenue of $838.75 million, indicating changes of -206.06% and 0%, respectively, compared to the previous year. Investors should also pay attention to any latest changes in analyst estimates for Tilray Brands, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. is holding a Zacks Rank of #3 (Hold) right now. The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 174, putting it in the bottom 30% of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow TLRY in the coming trading sessions, be sure to utilize Zacks.com. Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks